MyFinsight
Home
Blog
About
Short-term investments
$227,278K
(9.98%↑ Y/Y)
Cash and cash
equivalents
$37,483K
(-50.59%↓ Y/Y)
Prepaid expenses and
other current assets
$8,934K
(3.75%↑ Y/Y)
Total property and
equipment, gross
$10,427K
(-3.08%↓ Y/Y)
Total current assets
$273,695K
(-5.99%↓ Y/Y)
Long-term investments
$122,799K
(171.58%↑ Y/Y)
Other assets
$5,949K
(-23.29%↓ Y/Y)
Property and equipment,
net
$2,242K
(-18.83%↓ Y/Y)
Less accumulated
depreciation
$8,185K
(2.36%↑ Y/Y)
Total assets
$404,685K
(16.67%↑ Y/Y)
Total liabilities and
stockholders' equity
$404,685K
(16.67%↑ Y/Y)
Total stockholders'
equity
$381,256K
(17.67%↑ Y/Y)
Total liabilities
$23,429K
(2.48%↑ Y/Y)
Accumulated deficit
-$769,501K
(-22.31%↓ Y/Y)
Accumulated other
comprehensive (loss) income
-$1,018K
(-644.39%↓ Y/Y)
Additional paid-in capital
$1,151,764K
(20.86%↑ Y/Y)
Total current
liabilities
$20,756K
(14.99%↑ Y/Y)
Other long-term
liabilities
$2,673K
(-44.45%↓ Y/Y)
Common stock, 0.0001
par value...
$11K
(22.22%↑ Y/Y)
Accrued liabilities
$16,883K
(13.16%↑ Y/Y)
Accounts payable
$3,873K
(23.74%↑ Y/Y)
Back
Back
Balance Sheet
Oric Pharmaceuticals, Inc. (ORIC)
Oric Pharmaceuticals, Inc. (ORIC)
source: myfinsight.com